Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic amine compounds as CDK2 inhibitors

Tricyclic amine compounds as CDK2 inhibitors

US Patent 11440914 · Granted Sep 13, 2022

Estimated economic value: $113,403,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carboxamide compounds and uses thereof2025
Carboxamide compounds and uses thereof2025
Heterocyclic compounds as immunomodulators2025
Heterocyclic compounds as immunomodulators2025
Heterocyclic compounds as immunomodulators2025
Bicyclic amines as CDK2 inhibitors2025
Bicyclic amines as CDK2 inhibitors2025
Tricyclic compounds as inhibitors of KRAS2025
Pyrazolopyrimidine compounds and uses thereof2025
Pyrazolopyrimidine compounds and uses thereof2025
Naphthyridine compounds as inhibitors of KRAS2025
Tricyclic heterocycles as FGFR inhibitors2025